These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19492460)

  • 1. Acyclovir: the next new HIV drug?
    Proj Inf Perspect; 2009 Mar; (48):8-9. PubMed ID: 19492460
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 3. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].
    Brockmeyer NH; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863
    [No Abstract]   [Full Text] [Related]  

  • 4. Can HIV be eradicated?
    Pantaleo G; Perrin L
    AIDS; 1998; 12 Suppl A():S175-80. PubMed ID: 9633000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Without pharmacology nearly nothing can be accomplished in HIV medicine. Anti-HIV drugs: on the way to the IQ test!].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():101-2. PubMed ID: 11373759
    [No Abstract]   [Full Text] [Related]  

  • 6. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Campaign against a chameleon. Therapeutic strategies to control a survival artist].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():80-1. PubMed ID: 10863320
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes virus infections, HIV, and disease progression. Recommended, not required.
    Cotton D
    AIDS Clin Care; 1995 Feb; 7(2):15. PubMed ID: 12212539
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts.
    Cohen J
    Science; 2011 Dec; 334(6063):1614. PubMed ID: 22194536
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends. Aging HIV population faces unique health challenges, officials say.
    AIDS Policy Law; 2010 Oct; 25(11):1, 4. PubMed ID: 21053399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Administration of acyclovir (virustatic) to cats].
    Hirschberger J
    Tierarztl Prax; 1988; 16(4):427-30. PubMed ID: 2851884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latest on structured treatment interruptions.
    Proj Inf Perspect; 2000 Aug; (30):7-8. PubMed ID: 12171016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated development of viral inhibitor Thirovir for HIV.
    Drug News Perspect; 2003 Sep; 16(7):434. PubMed ID: 14672093
    [No Abstract]   [Full Text] [Related]  

  • 14. Chasing HIV from its hiding place.
    Erdmann J
    Chem Biol; 2010 Aug; 17(8):787-8. PubMed ID: 20797604
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing HIV. Understanding the pharmacodynamics.
    Miller SK
    Adv Nurse Pract; 2000 May; 8(5):58-60, 65-6. PubMed ID: 11235335
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic regulation of HIV expression.
    Fauci AS
    AIDS Res Hum Retroviruses; 1992 May; 8(5):707-10. PubMed ID: 1515220
    [No Abstract]   [Full Text] [Related]  

  • 17. Come out, come out. A recent study suggests a novel treatment might flush out latent copies of HIV hiding in the body--and re-ignites discussion over the challenges of eradicating HIV infection.
    Cohen P
    IAVI Rep; 2005; 9(5):1, 6-9. PubMed ID: 16541500
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of acyclovir on herpes virus infection and susceptibility of isolated virus to acyclovir.
    Muto S; Suzuki H; Yokota T; Shigeta S
    Fukushima J Med Sci; 1984 Feb; 30(1):19-27. PubMed ID: 6096237
    [No Abstract]   [Full Text] [Related]  

  • 19. Maturation inhibitors as new antiretroviral agents.
    Richards J; McCallister S
    J HIV Ther; 2008 Dec; 13(4):79-82. PubMed ID: 19418657
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.
    Nijhuis M; Wensing AM; Bierman WF; de Jong D; Kagan R; Fun A; Jaspers CA; Schurink KA; van Agtmael MA; Boucher CA
    J Infect Dis; 2009 Sep; 200(5):698-709. PubMed ID: 19627247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.